Sanofi (SNYNF) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Drug Manufacturers - General Branche. Der Hauptsitz des Unternehmens ist in Paris, France. Der aktuelle CEO ist Olivier Charmeil.
SNYNF hat IPO-Datum 2008-04-09, 82,878 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $114.08B.
Sanofi is a multinational pharmaceutical and healthcare company headquartered in Paris, France, engaged in the research, development, manufacture, and marketing of therapeutic solutions globally. The company operates through three core segments: Pharmaceuticals, Vaccines, and Consumer Healthcare, offering a diverse portfolio that includes specialty care products for multiple sclerosis, oncology, rare diseases, immunology, and diabetes; a comprehensive range of vaccines for pediatric and adult populations; and consumer health products spanning allergy relief, pain management, wellness, and dermatological care. With significant operations across the United States, Europe, and international markets, Sanofi collaborates with leading institutions and companies, including GlaxoSmithKline on COVID-19 vaccine development and Stanford University on immunology research, to advance its pipeline of innovative therapeutic solutions.
